novH: Differential expression in developing kidney and Wilms' tumors

American Journal of Pathology

Volumn 152, Issue 6, 1998, Pages 1563-1575

  Chevalier, Gaëlle ^a   Yeger, Herman ^b   Martinerie, Cécile ^a   Laurent, Maryvonne ^a   Alami, Jennifer ^b   Schofield, Paul N ^c   Perbal, Bernard ^a,d  

^a HÔPITAL SAINT ANTOINE   (France)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PROTEIN NOVH; UNCLASSIFIED DRUG;

ARTICLE; BECKWITH WIEDEMANN SYNDROME; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; DENYS DRASH SYNDROME; EMBRYO; GENE EXPRESSION; GLYCOSYLATION; HUMAN; HUMAN TISSUE; KIDNEY DEVELOPMENT; MESENCHYME; MUSCLE DEVELOPMENT; NEPHROBLASTOMA; NUCLEOTIDE SEQUENCE; PODOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DOGS; GENE EXPRESSION REGULATION; GLYCOSYLATION; GROWTH SUBSTANCES; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; RNA, MESSENGER; TIME FACTORS; WILMS TUMOR;

EID: 0031780105     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Breslow N, Beckwith JB, Ciol M, Sharples K: Age distribution of Wilms' tumor: report from the National Wilms' Tumor Study. Cancer Res 1988, 48:1653-1657
2. Breslow NE, Langholz B: Childhood cancer incidence: geographical and temporal variations. Int J Cancer 1983, 32:703-716
3. Matsunaga E: Genetics of Wilms' tumor. Hum Genet 1981, 57:231-246
4. Beckwith JB, Kiviat NB, Bonadio JF: Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol 1990, 10:1-36
5. Fearon ER, Vogelstein B, Feinberg AP: Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours. Nature 1984, 309:176-178
6. Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE: An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 1990, 61:1257-1269
7. Koufos A, Hansen MF, Lampkin BC, Workman ML, Copeland NG, Jenkins NA, Cavenee WK: Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumour. Nature 1984, 309:170-172
8. Maw MA, Grundy PE, Millow LJ, Eccles MR, Dunn RS, Smith PJ, Feinberg AP, Law DJ, Paterson MC, Telzerow PE, Caller DF, Thompson AD, Richards RI, Reeves AE: A third Wilms' tumor locus on chromosome 16q. Cancer Res 1992, 52:3094-3098
9. Newsham I, Kindler-Rohrborn A, Daub D, Cavenee W: A constitutional BWS-related t(11;16) chromosome translocation occurring in the same region of chromosome 16 implicated in Wilms' tumors. Genes Chromosomes & Cancer 1995, 12:1-7
10. Orkin SH, Goldman DS, Sallan SE: Development of homozygosity for chromosome 11p markers in Wilms' tumour. Nature 1984, 309:172-174
11. Peier AM, Meloni AM, Erling MA, Sandberg AA: Involvement of chromosome 7 in Wilms tumor. Cancer Genet Cytogenet 1995, 79:92-94
12. Radice P, Perotti D, De Benedetti V, Mondini P, Radice MT, Pilotti S, Luksch R, Fossati Bellani F, Pierotti MA: Allelotyping in Wilms tumors identifies a putative third tumor suppressor gene on chromosome 11. Genomics 1995, 27:497-501
13. Ton CC, Huff V, Call KM, Cohn S, Strong LC, Housman DE, Saunders GF: Smallest region of overlap in Wilms tumor deletions uniquely implicates an 11p13 zinc finger gene as the disease locus. Genomics 1991, 10:293-297
14. Pelletier J: Molecular genetics of Wilms' tumor: insights into normal and abnormal renal development. Can J Oncol 1994, 4:262-272
15. Hastie ND: The genetics of Wilms' tumor: a case of disrupted development. Annu Rev Genet 1994, 28:523-558
16. Chevalier G, Perbal B: Genetic alterations associated with pathologic differentiation of Wilms' tumors. Bull Cancer 1997, 84:289-303
17. Perbal B: Contribution of MAV-1-induced nephroblastoma to the study of genes involved in human Wilms' tumor development. Crit Rev Oncog 1994, 5:589-613
18. Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, Crochet J, Perbal B: Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol 1992, 12:10-21
19. Bork P: The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 1993, 327:125-130
20. Bradham DM, Igarashi A, Potter RL, Grotendorst GR: Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991, 114:1285-1294
21. Grotendorst GR, Okochi H, Hayashi N: A novel transforming growth factor β response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 1996, 7:469-480
22. Ryseck RP, Macdonald-Bravo H, Mattei MG, Bravo R: Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ 1991, 2:225-233
23. O'Brien TP, Yang GP, Sanders L, Lau LF: Expression of cyr61, a growth factor-inducible immediate-early gene. Mol Cell Biol 1990, 10:3569-3577
24. O'Brien TP, Lau LF: Expression of the growth factor-inducible immediate early gene cyr61 correlates with chondrogenesis during mouse embryonic development. Cell Growth Differ 1992, 3:645-654
25. Yang GP, Lau LF: Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth Differ 1991, 2:351-357
26. Kireeva ML, Mo FE, Yang GP, Lau LF: Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol 1996, 16:1326-1334
27. Simmons DL, Levy DB, Yannoni Y, Erikson RL: Identification of a phorbol ester-repressible v-src-inducible gene. Proc Natl Acad Sci USA 1989, 86:1178-1182
28. Scholz G, Martinerie C, Perbal B, Hanafusa H: Transcriptional down regulation of the nov proto-oncogene in fibroblasts transformed by p60v-src. Mol Cell Biol 1996, 16:481-486
29. Martinerie C, Chevalier G, Rauscher F Jr, Perbal B: Regulation of nov by WT1: a potential role for nov in nephrogenesis. Oncogene 1996, 12:1479-1492
30. Martinerie C, Huff V, Joubert I, Badzioch M, Saunders G, Strong L, Perbal B: Structural analysis of the human nov proto-oncogene and expression in Wilms tumor. Oncogene 1994, 9:2729-2732
31. Yeger H, Cullinane C, Flenniken A, Chilton-MacNeil S, Campbell C, Huang A, Bonetta L, Coppes MJ, Thorner P, Williams BR: Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes. Cell Growth Differ 1992, 3:855-864
32. Lahoti C, Thorner P, Malkin D, Yeger H: Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome. Am J Pathol 1996, 148:1577-1589
33. Patwardhan S, Gashler A, Siegel MG, Chang LC, Joseph LJ, Shows TB, Le Beau MM, Sukhatme VP: EGR3, a novel member of the Egr family of genes encoding immediate-early transcription factors. Oncogene 1991, 6:917-928
34. Louvard D: Apical membrane aminopeptidase appears at site of cell-cell contact in cultured kidney epithelial cells. Proc Natl Acad Sci USA 1980, 77:4132-4136
35. Perbal B: A Practical Guide to Molecular Cloning. New York, John Wiley & Sons, 1988
36. Van Regenmortel MH, Briand JP, Muller S, Plaue S: Synthetic polypeptides as antigens. Laboratory Techniques in Biochemistry and Molecular Biology. Edited by RH Gurdon, PH Van Kanippenberg. Amsterdam, Elsevier, 1990, pp 95-144
37. Yeger H, Forget D, Alami J, Williams BR: Analysis of WT1 gene expression during mouse nephrogenesis in organ culture. In Vitro Cell Dev Biol Anim 1996, 32:496-504
38. Kim H, Yeger H, Han R, Wallace M, Goldstein B, Rotin D: Expression of LAR-PTP2 in rat lung is confined to proliferating epithelia lining the airways and air sacs. Am J Physiol 1996, 270:L566-L576
39. Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI, Slingerland JM: Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nature Med 1997, 3:227-230
40. Kim HS, Nagalla SR, Oh Y, Wilson E, Roberts CT Jr, Rosenfeld RG: Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci USA 1997, 94:12981-12986
41. Coppes MJ, Liefers GJ, Paul P, Yeger H, Williams BR: Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor. Proc Natl Acad Sci USA 1993, 90:1416-1419
42. Baird PN, Groves N, Haber DA, Housman DE, Cowell JK: Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome. Oncogene 1992, 7:2141-2149
43. Coppes MJ, Clericuzio CL: Molecular genetic analysis of the WT1 gene in patients suspected to have the Denys-Drash syndrome. Med Pediatr Oncol 1994, 23:390
44. Ladanyi M, Gerald W: Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 1994, 54:2837-2840
45. Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN, Reddy ES: The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts, and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene 1994, 9:3087-3097
46. Brodie SG, Stocker SJ, Wardlaw JC, Duncan MH, McConnell TS, Feddersen RM, Williams TM: EWS and WT-1 gene fusion in desmo-plastic small round cell tumor of the abdomen. Hum Pathol 1995, 26:1370-1374
47. Grubb GR, Yun K, Williams BR, Eccles MR, Reeve AE: Expression of WT1 protein in fetal kidneys and Wilms tumors. Lab Invest 1994, 71:472-479
48. Mundlos S, Pelletier J, Darveau A, Bachmann M, Winterpacht A, Zabel B: Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development 1993, 119:1329-1341
49. Ye Y, Raychaudhuri B, Gurney A, Campbell CE, Williams BR: Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. EMBO J 1996, 15:5606-5615
50. Maheswaran S, Park S, Bernard A, Morris JF, Rauscher F Jr, Hill DE, Haber DA: Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci USA 1993, 90:5100-5104
51. Maheswaran S, Englert C, Bennett P, Heinrich G, Haber DA: The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev 1995, 9:2143-2156
52. Johnstone RW, See RH, Sells SF, Wang J, Muthukkumar S, Englert C, Haber DA, Licht JD, Sugrue SP, Roberts T, Rangnekar VM, Shi Y: A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol Cell Biol 1996, 16:6945-6956
53. Wang Z, Qiu Q, Gurrieri M, Huang J, Deuel T: WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. Oncogene 1995, 10:1243-1247
54. Saksela O, Moscatelli D, Sommer A, Rifkin DB: Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol 1988, 107:743-751
55. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, Lose EJ: Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 1992, 8:365-393
56. Varki A: Biological roles of oligosaccharides. All of the theories are correct. Glycobiology 1993, 3:97-130
57. Reeve AE, Eccles MR, Wilkins RJ, Bell GI, Millow LJ: Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature 1985, 317:258-260
58. Scott J, Cowell J, Robertson ME, Priestley LM, Wadey R, Hopkins B, Pritchard J, Bell GI, Rall LB, Graham CF, Knott TJ: Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues. Nature 1985, 317:260-262
59. Haselbacher GK, Irminger JC, Zapf J, Ziegler WH, Humbel RE: Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level. Proc Natl Acad Sci USA 1987, 84:1104-1106
60. Gansler T, Allen KD, Burant CF, Inabnett T, Scott A, Buse MG, Sens DA, Garvin AJ: Detection of type 1 insulin-like growth factor (IGF) receptors in Wilms' tumors. Am J Pathol 1988, 130:431-435
61. Werner H, Rauscher F Jr, Sukhatme VP, Drummond IA, Sukhatme VP, Rauscher F Jr, Sens DA, Garvin AJ, LeRoith D, Roberts CT Jr: Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc Natl Acad Sci USA 1993, 90:5828-5832
62. Werner H, Rauscher F Jr, Sukhatme VP, Drummond IA, Roberts CT Jr, LeRoith D: Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J Biol Chem 1994, 269:12577-12582